Stent Prices
- All
- News
- Videos
- Web Stories
-
Not Just Stents. India Rejects US Request For Medical Devices Price Caps
India has told the US it won't abstain from capping prices for more medical devices, regardless of pressure to rethink its stance after price controls on heart stents and knee implants spoilt the market for some US firms, sources familiar with the matter said
-
In "Larger Public Interest", Stent Prices Further Cut By Over 6%
Shashank Kapoor, 32, is overjoyed. Last month, his father suffered a cardiac arrest and needed two stents. The five-day stay at a private hospital set the counsellor back by over Rs 1 lakh, one-third of which was just the price of the two stents.
-
US President Donald Trump Promises Action On Drug Prices That May Impact India
US President Donald Trump has promised to bring the cost of prescription drugs way down and let other countries pay more for these medicines in a new policy that could have implications for India.
-
Good News For Cardiac Patients! Govt Slashes Prices Of Stents By Up to 85%
The maximum retail price of bare metal stents (BMS) and drug eluting stents (DES) will be Rs 7,623 and Rs 31,080, respectively, inclusive of VAT and other local taxes.
-
After Stents, Government Caps Prices Of Knee Implants. Details Here
The government had in February slashed the maximum price of life-saving heart stent implants by up to 85 per cent.
-
Government Tells Hospitals To Follow Notification On Capping Stent Prices
The Union health ministry has directed all hospitals, including privates ones, to follow its February notification on capping the prices of stents.
-
Drug-Pricing Regulator Wants Medical Devices Added To Price Control List
The National Pharmaceutical Pricing Authority (NPPA) had said it did not plan further measures after prices of some heart stents were cut in February by 75 percent
-
Welcome Centre's Decision To Regulate Prices Of Coronary Stents: Pema Khandu
Arunachal Pradesh Chief Minister Pema Khandu has welcomed the Centre's decision to regulate the prices of coronary stents and extended his government's support to the Ministry of Chemicals and Fertilisers.
-
PM Narendra Modi Hints At Rules For Doctors To Prescribe Generic Drugs
Prime Minister Narendra Modi today indicated that his government may bring in a legal framework under which doctors will have to prescribe generic medicines, which are cheaper than equivalent branded drugs, to patients. PM Modi said his government brought in a health policy after 15 years and capped the prices of medicines and stents, which has ang...
-
Price Cap On Stents Hailed By All, But Serious Concerns Remain
The drug pricing regulator has directed that in cases of evidence of artificial stent shortage, the state governments can proceed against the manufacturers and seize their stent stocks as per the provisions of the Drug Price Control Order, 2013.
-
Price Cap On Stents Hailed By All, But Serious Concerns Remain
The drug pricing regulator has directed that in cases of evidence of artificial stent shortage, the state governments can proceed against the manufacturers and seize their stent stocks as per the provisions of the Drug Price Control Order, 2013.
-
Drug Pricing Regulator To Soon Fix Ceiling Rates Of Stents
The Department of Pharmaceuticals has in a notification put bare metal stents and drug eluting stents (DES) in the Schedule I of DPCO 2013.
-
Not Just Stents. India Rejects US Request For Medical Devices Price Caps
India has told the US it won't abstain from capping prices for more medical devices, regardless of pressure to rethink its stance after price controls on heart stents and knee implants spoilt the market for some US firms, sources familiar with the matter said
-
In "Larger Public Interest", Stent Prices Further Cut By Over 6%
Shashank Kapoor, 32, is overjoyed. Last month, his father suffered a cardiac arrest and needed two stents. The five-day stay at a private hospital set the counsellor back by over Rs 1 lakh, one-third of which was just the price of the two stents.
-
US President Donald Trump Promises Action On Drug Prices That May Impact India
US President Donald Trump has promised to bring the cost of prescription drugs way down and let other countries pay more for these medicines in a new policy that could have implications for India.
-
Good News For Cardiac Patients! Govt Slashes Prices Of Stents By Up to 85%
The maximum retail price of bare metal stents (BMS) and drug eluting stents (DES) will be Rs 7,623 and Rs 31,080, respectively, inclusive of VAT and other local taxes.
-
After Stents, Government Caps Prices Of Knee Implants. Details Here
The government had in February slashed the maximum price of life-saving heart stent implants by up to 85 per cent.
-
Government Tells Hospitals To Follow Notification On Capping Stent Prices
The Union health ministry has directed all hospitals, including privates ones, to follow its February notification on capping the prices of stents.
-
Drug-Pricing Regulator Wants Medical Devices Added To Price Control List
The National Pharmaceutical Pricing Authority (NPPA) had said it did not plan further measures after prices of some heart stents were cut in February by 75 percent
-
Welcome Centre's Decision To Regulate Prices Of Coronary Stents: Pema Khandu
Arunachal Pradesh Chief Minister Pema Khandu has welcomed the Centre's decision to regulate the prices of coronary stents and extended his government's support to the Ministry of Chemicals and Fertilisers.
-
PM Narendra Modi Hints At Rules For Doctors To Prescribe Generic Drugs
Prime Minister Narendra Modi today indicated that his government may bring in a legal framework under which doctors will have to prescribe generic medicines, which are cheaper than equivalent branded drugs, to patients. PM Modi said his government brought in a health policy after 15 years and capped the prices of medicines and stents, which has ang...
-
Price Cap On Stents Hailed By All, But Serious Concerns Remain
The drug pricing regulator has directed that in cases of evidence of artificial stent shortage, the state governments can proceed against the manufacturers and seize their stent stocks as per the provisions of the Drug Price Control Order, 2013.
-
Price Cap On Stents Hailed By All, But Serious Concerns Remain
The drug pricing regulator has directed that in cases of evidence of artificial stent shortage, the state governments can proceed against the manufacturers and seize their stent stocks as per the provisions of the Drug Price Control Order, 2013.
-
Drug Pricing Regulator To Soon Fix Ceiling Rates Of Stents
The Department of Pharmaceuticals has in a notification put bare metal stents and drug eluting stents (DES) in the Schedule I of DPCO 2013.
